Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) insider Dawn Christine Maroney sold 4,274 shares of the company's stock in a transaction that occurred on Wednesday, December 21st. The shares were sold at an average price of $12.01, for a total value of $51,330.74. Following the completion of the transaction, the insider now directly owns 1,970,692 shares of the company's stock, valued at $23,668,010.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Dawn Christine Maroney also recently made the following trade(s):
Get
Alignment Healthcare alerts:
- On Thursday, December 15th, Dawn Christine Maroney sold 726 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.02, for a total value of $8,726.52.
Alignment Healthcare Trading Down 1.3 %
NASDAQ ALHC opened at $11.73 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.03 and a quick ratio of 2.03. The company's 50 day moving average is $12.26 and its 200-day moving average is $13.18. Alignment Healthcare, Inc. has a 12-month low of $6.14 and a 12-month high of $19.17.
Alignment Healthcare (NASDAQ:ALHC – Get Rating) last released its quarterly earnings data on Thursday, November 3rd. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.25) by $0.03. The business had revenue of $360.35 million during the quarter, compared to analyst estimates of $333.65 million. Alignment Healthcare had a negative net
margin of 10.25% and a negative return on equity of 48.22%. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.81 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the company. Piper Sandler reiterated an "overweight" rating and set a $19.00 target price on shares of Alignment Healthcare in a research note on Thursday, September 8th. Raymond James cut shares of Alignment Healthcare from an "outperform" rating to a "market perform" rating in a research note on Monday, November 21st. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $18.40.
Institutional Trading of Alignment Healthcare
A number of hedge funds and other institutional investors have recently made changes to their positions in ALHC. Victory Capital Management Inc. grew its holdings in Alignment Healthcare by 10.4% during the 1st quarter. Victory Capital Management Inc. now owns 11,124 shares of the company's stock valued at $107,000 after buying an additional 1,045 shares in the last quarter. Swiss National Bank grew its stake in Alignment Healthcare by 7.3% during the first quarter. Swiss National Bank now owns 88,500 shares of the company's stock valued at $994,000 after acquiring an additional 6,000 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Alignment Healthcare by 7.7% during the 1st quarter. Principal Financial Group Inc. now owns 14,524 shares of the company's stock worth $163,000 after acquiring an additional 1,034 shares during the period. Eagle Asset Management Inc. lifted its stake in Alignment Healthcare by 9.2% in the 1st quarter. Eagle Asset Management Inc. now owns 745,657 shares of the company's stock worth $8,373,000 after purchasing an additional 62,521 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its holdings in Alignment Healthcare by 55.4% in the 1st quarter. MetLife Investment Management LLC now owns 45,938 shares of the company's stock valued at $516,000 after purchasing an additional 16,380 shares during the period. 83.49% of the stock is currently owned by institutional investors.
About Alignment Healthcare
(Get Rating)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.
Further Reading
- Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
- Your Decision to Buy Palantir May Simply Be a Matter of Time
- Are Caterpillar and Deere Setting Up to Rally in 2023?
- Mullen Automotive Gets a Jolt as the I-GO Arrives in Europe
- Will The Sun Shine On These 3 Large-Cap Solar Stocks In 2023?
- Lucid Motors Faces a Reality That May Cloud a Bullish Perception
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
